Skip to main content
SpringerLink
Log in

Analysis of Drug Impurities

  • Chapter
Handbook of Trace Analysis

Abstract

Although the development of trace analysis is considered to have begun with studies related to the determination of trace elements, from the pharmaceutical point of view, the beginning of this field of science should be sought in the analysis of drugs and especially in the search for active compounds in different types of pharmaceutical decoctions, tinctures, and macerations. Isolation of opium and later morphine from poppy juice, or isolation of quinine from cinchona tree bark, were nothing other than preparation and concentration of a sample before performing trace analysis [1–3].

Barbara Marciniec was deceased at the time of publication

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lahiri, S.: Advanced Trace Analysis. Narosa Publishing House, New Delhi (2009)

    Google Scholar 

  2. Bartley, E.H.: Text-Book of Medical and Pharmaceutical Chemistry. Nabu Press, London (2010)

    Google Scholar 

  3. Gunzler, H., Williams, A.: Handbook of Analytical Techniques. Wiley, Weinheim (2001)

    Book  Google Scholar 

  4. United States Pharmacopeia 38th ed. Rockville, Maryland (2014)

    Google Scholar 

  5. The European Pharmacopoeia, 8th ed. Council of Europe, European Committee on Pharmaceuticals and Pharmaceutical Care (2014)

    Google Scholar 

  6. Geiling, E.M.K., Cannon, P.R.: Pathogenic effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA 111, 919–926 (1938)

    Article  CAS  Google Scholar 

  7. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Q3A(R3): Impurities in New Drug Substances (2002)

    Google Scholar 

  8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Q3B(R3): Impurities in New Drug Products (2003)

    Google Scholar 

  9. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Q3C(R3): Impurities: Residual Solvents (2005)

    Google Scholar 

  10. Gorog, S., Babjak, M., Balogh, G., Brlik, J., Csehi, A., Dravecz, F., Gazdag, M., Horvath, P., Lauko, A., Varga, K.: Drug impurity profiling strategies. Talanta 44, 1517–1526 (1997)

    Article  CAS  Google Scholar 

  11. Gorog, S.: Chemical and analytical characterization of related organic impurities in drugs. Anal. Bioanal. Chem. 377, 852–862 (2003)

    Article  Google Scholar 

  12. Gorog, S.: The importance and the challenges of impurity profiling in modern pharmaceutical analysis. Trends Anal. Chem. 25, 755–757 (2006)

    Article  Google Scholar 

  13. Ng, L., Lunn, G., Faustyno, P.: Organic impurities in drug substance: origin, control and measurement. In: Smith, R.J., Webb, M.L. (eds.) Analysis of Drug Impurities. Blackwell, Oxford (2007)

    Google Scholar 

  14. Gorog, S.: The nature and origin of the impurities in drug substances. In: Gorog, S. (ed.) Identification and Determination of Impurities in Drugs. Elsevier, Amsterdam (2000)

    Google Scholar 

  15. Ahuja, S.: Overview: isolation and characterization of impurities. In: Ahuja, S., Alsante, K.M. (eds.) Handbook of Isolation and Characterization of Impurities in Pharmaceuticals. Academic, San Diego (2003)

    Google Scholar 

  16. Gorog, S.: Drug safety, drug quality, drug analysis. J. Pharm. Biomed. Anal. 48, 247–253 (2008)

    Article  CAS  Google Scholar 

  17. McGovern, T., Jacobson-Kram, D.: Regulation of genotoxic and carcinogenic impurities in drug substances and products. Trends Anal. Chem. 25, 790–795 (2006)

    Article  CAS  Google Scholar 

  18. Smith, R.J., Webb, M.L. (eds.): Analysis of Drug Impurities. Blackwell, Oxford (2007)

    Google Scholar 

  19. Gorog, S. (ed.): Identification and Determination of Impurities in Drugs. Elsevier, Amsterdam (2000)

    Google Scholar 

  20. Ahuja, S., Alsante, K.M. (eds.): Handbook of Isolation and Characterization of Impurities in Pharmaceuticals. San Diego, Academic Press (2003)

    Google Scholar 

  21. Bartos, D., Gorog, S.: Recent advances in the impurity profiling of drugs. Curr. Pharm. Anal. 4, 215–230 (2008)

    Article  CAS  Google Scholar 

  22. Gorog, S.: New safe medicines faster: the role of analytical chemistry. Trends Anal. Chem. 22, 407–415 (2003)

    Article  CAS  Google Scholar 

  23. Rahman, N., Najmul, S., Azmi, H., Wu, H.F.: The importance of impurity analysis in pharmaceutical products: an integrated approach. Accred. Qual. Assur. 11, 69–74 (2006)

    Article  CAS  Google Scholar 

  24. Baertschi, S.W.: Analytical methodologies for discovering and profiling degradation-related impurities. Trends Anal. Chem. 25, 758–767 (2006)

    Article  CAS  Google Scholar 

  25. Niessen, W.M.A.: LC MS and CE MS strategies in impurity profiling. Chimia 53, 478–483 (1999)

    CAS  Google Scholar 

  26. Olsen, B.A., Castle, B.C., Myers, D.P.: Advances in HPLC technology for the determination of drug impurities. Trends Anal. Chem. 25, 796–805 (2006)

    Article  CAS  Google Scholar 

  27. Kamberi, M., Riley, C.M., Ma, X., Huang, C.W.J.: A validated, sensitive HPLC method for the determination of trace impurities in acetaminophen drug substance. J. Pharm. Biomed. Anal. 34, 123–128 (2004)

    Article  CAS  Google Scholar 

  28. Yasueda, S.I., Higashiyama, M., Shirasaki, Y., Inada, K., Ohtori, A.J.: An HPLC method to evaluate purity of a steroidal drug, loteprednol etabonate. J. Pharm. Biomed. Anal. 36, 309–316 (2004)

    Article  CAS  Google Scholar 

  29. Tzanavaras, P.D., Themelis, D.G.J.: High-throughput HPLC assay of acyclovir and its major impurity guanine using a monolithic column and a flow gradient approach. J. Pharm. Biomed. Anal. 43, 1526–1530 (2007)

    Article  CAS  Google Scholar 

  30. Liu, J., Sun, J., Zhang, W., Gao, K., He, Z.J.: HPLC determination of rifampicin and related compounds in pharmaceuticals using monolithic column. J. Pharm. Biomed. Anal. 46, 405–409 (2008)

    Article  CAS  Google Scholar 

  31. Malenovic, A., Medenica, M., Ivanovic, D., Jancic, B.: Monitoring of simvastatin impurities by HPLC with microemulsion eluents. Chromatographia 63, 95–100 (2006)

    Article  Google Scholar 

  32. McEvoy, E., Donegan, S., Power, J., Altria, K.D.: Optimisation and validation of a rapid and efficient microemulsion liquid chromatographic (MELC) method for the determination of paracetamol (acetaminophen) content in a suppository formulation. J. Pharm. Biomed. Anal. 44, 137–143 (2007)

    Article  CAS  Google Scholar 

  33. Hanko, V.P., Rohrer, J.S.J.: Determination of neomycin sulfate and impurities using high-performance anion-exchange chromatography with integrated pulsed amperometric detection. J. Pharm. Biomed. Anal. 43, 131–141 (2007)

    Article  CAS  Google Scholar 

  34. Zawilla, N.H., Li, B., Hoogmartens, J., Adams, E.: Improved reversed-phase liquid chromatographic method combined with pulsed electrochemical detection for the analysis of amikacin. J. Pharm. Biomed. Anal. 43, 168–173 (2007)

    Article  CAS  Google Scholar 

  35. Council of Europe: European Pharmacopoeia, vol. 2, 5th edn, p. 968. Council of Europe, Strasbourg (2005)

    Google Scholar 

  36. Berezkin, V.: The discovery of thin layer chromatography. J. Planar Chromatogr. 8, 401–405 (1995)

    CAS  Google Scholar 

  37. Krzek, J., Hubicka, U., Szczenpanczyk, J.: High performance thin layer chromatography with densitometry for the determination of ciprofloxacin and impurities in drugs. J. AOAC Int. 88, 1530–1536 (2005)

    CAS  Google Scholar 

  38. Maslanka, A., Krzek, J.: Use of TLC with densitometric detection for determination of impurities in chlorpromazine hydrochloride, trifluoperazine dihydrochloride, promazine hydrochloride, and doxepin hydrochloride. J. Planar Chromatogr. 20, 463–475 (2007)

    Article  CAS  Google Scholar 

  39. Anjaneyulu, Y., Marayya, R., Linga, R.D., Krishna, R.P.: High performance thin layer chromatographic determination of the related substances in alprazolam drug. Asian J. Chem. 19, 3375–3381 (2007)

    CAS  Google Scholar 

  40. Agbaba, D., Novovic, D., Karljikovic-Rajic, K., Marinkovic, V.: Densitometric determination of omeprazole, pantoprazole, and their impurities in pharmaceuticals. J. Planar Chromatogr. 17, 169–172 (2004)

    Article  CAS  Google Scholar 

  41. Naidong, W., Hua, S., Roets, E., Hoogmartens, J.: Assay and purity control of tetracycline, chlortetracycline and oxytetracycline in animal feeds and premixes by TLC densitometry with fluorescence detection. J. Pharm. Biomed. Anal. 33, 85–93 (2003)

    Article  Google Scholar 

  42. Ferenczi-Fodor, K., Végh, Z., Renger, B.: Thin-layer chromatography in testing the purity of pharmaceuticals. Trends Anal. Chem. 25, 778–789 (2006)

    Article  CAS  Google Scholar 

  43. Okafo, G.N., Camilleri, P.: Micellar electrokinetic capillary chromatography of amoxycillin and related molecules. Analyst 117, 1421–1424 (1992)

    Article  CAS  Google Scholar 

  44. Lurie, I.S., Hays, P.A., Garcia, A.E., Panicker, S.: Use of dynamically coated capillaries for the determination of heroin, basic impurities and adulterants with capillary electrophoresis. J. Chromatogr. A 1034, 227–235 (2004)

    Article  CAS  Google Scholar 

  45. Thomas, B.R., Fang, X.G., Chen, X., Tyrrell, R.J., Ghodbane, S.: Validated micellar electrokinetic capillary chromatography method for quality control of the drug substances hydrochlorothiazide and chlorothiazide. J. Chromatogr. B Biomed. Sci. Appl. 657, 383–394 (1994)

    Article  CAS  Google Scholar 

  46. Hansen, S.H., Sheribah, Z.A.: Comparison of CZE, MEKC, MEEKC and non-aqueous capillary electrophoresis for the determination of impurities in bromazepam. J. Pharm. Biomed. Anal. 39, 322–327 (2005)

    Article  CAS  Google Scholar 

  47. Tjornelund, J., Hansen, S.H.: Determination of impurities in tetracycline hydrochloride by non-aqueous capillary electrophoresis. J. Chromatogr. A 737, 291–300 (1996)

    Article  Google Scholar 

  48. Stubberud, K.P., Astrom, O.: Separation of ibuprofen, codeine phosphate, their degradation products and impurities by capillary electrophoresis: II. Validation. J. Chromatogr. A 826, 95–102 (1998)

    Article  CAS  Google Scholar 

  49. Clarke, H.J., Norris, K.J.: Sample selection for analytical method development. In: Ahuja, S., Alsante, K.M. (eds.) Handbook of Isolation and Characterization of Impurities in Pharmaceuticals. Academic, San Diego (2003)

    Google Scholar 

  50. Karpińska, J.: Derivative spectrophotometry - recent applications and directions of developments. Talanta 64, 801–822 (2004)

    Article  Google Scholar 

  51. Lang, J.K. (ed.): Handbook on Mass Spectrometry: Instrumentation, Data and Analysis and Applications. Nova Science, New York (2010)

    Google Scholar 

  52. Mak, M., Czira, G., Brlik, J.: Mass spectrometry in impurity profiling. In: Görög, S. (ed.) Identification and Determination of Impurities in Drugs. Elsevier, Amsterdam (2000)

    Google Scholar 

  53. Daabees, H.G.: The use of derivative spectrophotometry for the determination of acyclovir and diloxanide furoate in presence of impurity or degradation product. Anal. Lett. 31, 1509–1522 (1998)

    Article  CAS  Google Scholar 

  54. Hasan, N.Y., Abdel-Elkawy, M., Elzany, B.E., Wagieh, N.E.: Stability indicating methods for the determination of aceclofenac. Farmaco 58, 91–99 (2003)

    Article  CAS  Google Scholar 

  55. Ragno, G., Garofalo, A., Vetuschi, C.: Photodegradation monitoring of amlodipine by derivative spectrophotometry. J. Pharm. Biomed. Anal. 27, 19–24 (2002)

    Article  CAS  Google Scholar 

  56. Kelani, K., Bebavy, L.I., Abdel, F.L.: Stability-indicating spectrophotometric and densitometric methods for determination of some cephalosporins. J. AOAC Int. 81, 386–393 (1998)

    CAS  Google Scholar 

  57. Bebawy, L.I., El Kousy, N.: Stability-indicating method for the determination of hydrochlorothiazide, benzydamine hydrochloride and clonazepam in the presence of their degradation products. Anal. Lett. 30, 1379–1397 (1997)

    Article  CAS  Google Scholar 

  58. Hassan, E.M.: Determination of ipratropium bromide in vials using kinetic and first-derivative spectrophotometric methods. J. Pharm. Biomed. Anal. 21, 1183–1189 (2000)

    Article  CAS  Google Scholar 

  59. Bebawy, L.I.: Stability-indicating method for the determination of meloxicam and tetracaine hydrochloride in the presence of their degradation products. Spectrosc. Lett. 31, 797–820 (1998)

    Article  CAS  Google Scholar 

  60. El Kousy, N.M., Bebawy, L.I.: Stability-indicating methods for determining omeprazole and octylonium bromide in the presence of their degradation products. J. AOAC Int. 82, 599–606 (1999)

    Google Scholar 

  61. Moustafa, A.A., Bibawy, L.I.: Stability-indicating assay of secnidazole in the presence of its degradation products. Spectrosc. Lett. 32, 1073–1098 (1999)

    Article  CAS  Google Scholar 

  62. Zhou, L., Mao, B., Reamer, R., Novak, T., Ge, Z.: Impurity profile tracking for active pharmaceutical ingredients: Case reports. J. Pharm. Biomed. Anal. 44, 421–429 (2007)

    Article  CAS  Google Scholar 

  63. Bharathi, C., Prabahar, K.J., Prasad, C.S., Kumar, M.S., Magesh, S., Handa, V.K., Dandala, R., Naidu, A.: Impurity profile study of zaleplon. J. Pharm. Biomed. Anal. 44, 101–109 (2007)

    Article  CAS  Google Scholar 

  64. Hartman, R., Abrahim, A., Clausen, A., Mao, B., Crocker, L.S., Ge, Z.: J. Liq. Chromatogr. Relat. Technol. 26, 2551–2566 (2003)

    Article  CAS  Google Scholar 

  65. Babják, M., Balogh, G., Gazdag, M., Gorog, S.: Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate. J. Pharm. Biomed. Anal. 29, 1153–1157 (2002)

    Article  Google Scholar 

  66. Raj, T.J.S., Bharati, C.H., Rao, K.R., Rao, P.S., Narayan, G.K., Parikh, K.: Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms. J. Pharm. Biomed. Anal. 43, 1470–1475 (2007)

    Article  CAS  Google Scholar 

  67. Shinde, V., Trivedi, A., Upadhayay, P.R., Gupta, N.L., Kanase, D.G., Chikate, R.C.: Degradation mechanism for a trace impurity in quinapril drug by tandem mass and precursor ions studies. Rapid Commun. Mass Spectrom. 21, 3156–3160 (2007)

    Article  CAS  Google Scholar 

  68. Tollsten, L.: HPLC/MS for drug impurity identification. In: Görög, S. (ed.) Identification and Determination of Impurities in Drugs. Elsevier, Amsterdam (2000)

    Google Scholar 

  69. Smyth, W.F.: Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography–electrospray ionisation mass spectrometry. J. Chromotogr. B 824, 1–20 (2005)

    Article  CAS  Google Scholar 

  70. Qiu, F., Norwood, D.L.: Identification of pharmaceutical impurities. J. Liq. Chromatogr. Relat. Technol. 30, 877–935 (2007)

    Article  CAS  Google Scholar 

  71. Laniewski, K., Wännman, T., Hagman, G.: Gas chromatography with mass spectrometric, atomic emission and Fourier transform infrared spectroscopic detection as complementary analytical techniques for the identification of unknown impurities in pharmaceutical analysis. J. Chromatogr. A 985, 275–282 (2003)

    Article  CAS  Google Scholar 

  72. Laniewski, K., Vagerö, M., Forsberg, E., Forngren, T., Hagman, G.: Complementary use of gas chromatography–mass spectrometry, gas chromatography–atomic emission detection and nuclear magnetic resonance for identification of pharmaceutically related impurities of unknown structures. J. Chromatogr. A 1027, 93–102 (2004)

    Article  CAS  Google Scholar 

  73. Pan, C., Liu, F., Ji, Q., Wang, W., Drinkwater, D., Vivilecchia, R.: The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development. J. Pharm. Biomed. Anal. 40, 581–590 (2006)

    Article  CAS  Google Scholar 

  74. Dayrit, F.M., Dumlao, M.C.: Impurity profiling of methamphetamine hydrochloride drugs seized in the Philippines. Forensic Sci. Int. 144, 29–36 (2004)

    Article  CAS  Google Scholar 

  75. Visky, D., Jimidar, I., Van Ael, W., Vennekens, T., Redlich, D., deSmet, M.: Capillary electrophoresis-mass spectrometry in impurity profiling of pharmaceutical products. Electrophoresis 26, 1541–1549 (2005)

    Article  CAS  Google Scholar 

  76. Vassort, A., Barrett, D.A., Shaw, P.N., Ferguson, P.D., Szucs, R.: A generic approach to the impurity profiling of drugs using standardised and independent capillary zone electrophoresis methods coupled to electrospray ionisation mass spectrometry. Electrophoresis 26, 1712–1723 (2005)

    Article  CAS  Google Scholar 

  77. Castro-Puyana, M., García-Ruiz, C., Cifuentes, A., Crego, A.L., Marina, M.L.J.: Identification and quantitation of cis-ketoconazole impurity by capillary zone electrophoresis–mass spectrometry. J. Chromatogr. A 1114, 170–177 (2006)

    Article  CAS  Google Scholar 

  78. Stubberud, K., Callmer, K., Westerlund, D.: Partial filling-micellar electrokinetic chromatography optimization studies of ibuprofen, codeine and degradation products, and coupling to mass spectrometry: Part II. Electrophoresis 24, 1008–1015 (2003)

    Article  CAS  Google Scholar 

  79. Mol, R., De Jong, G.J., Somsen, G.W.: Atmospheric pressure photoionization for enhanced compatibility in on-line micellar electrokinetic chromatography − mass spectrometry. Anal. Chem. 77, 5277–5282 (2005)

    Article  CAS  Google Scholar 

  80. Mol, R., Kragt, E., Jimidar, I., De Jong, G.J., Somsen, G.W.: Micellar electrokinetic chromatography–electrospray ionization mass spectrometry for the identification of drug impurities. J. Chromatogr. B 843, 283–288 (2006)

    Article  CAS  Google Scholar 

  81. Kellner, R., Otto, M., Widmer, H.M., Mermet, J.M. (eds.): Analytical Chemistry. Wiley, New York (1998)

    Google Scholar 

  82. Nicholson, J.K., Lindon, J.C., Scarfe, G., Wilson, I.D., Abou-Shakra, F., Castro-Perez, J., Eaton, A., Preece, S.: High-performance liquid chromatography and inductively coupled plasma mass spectrometry (HPLC ICP MS) for the analysis of xenobiotic metabolites in rat urine: application to the metabolites of 4-bromoaniline. Analyst 125, 235–236 (2000)

    Article  CAS  Google Scholar 

  83. Baker, S.A., Miller-Ihli, N.J.: Determination of cobalamins using capillary electrophoresis inductively coupled plasma mass spectrometry. Spectrochim. Acta B 55, 1823–1832 (2000)

    Article  Google Scholar 

  84. Evans, E.H., Wolff, J.C., Eckers, C.: Sulfur-specific detection of impurities in cimetidine drug substance using liquid chromatography coupled to high resolution inductively coupled plasma mass spectrometry and electrospray mass spectrometry. Anal. Chem. 73, 4722–4728 (2001)

    Article  CAS  Google Scholar 

  85. Wind, M., Edler, M., Jakubowski, N., Linscheid, M., Wesch, H., Lehmann, W.D.: Analysis of protein phosphorylation by capillary liquid chromatography coupled to element mass spectrometry with 31P detection and to electrospray mass spectrometry. Anal. Chem. 73, 29–35 (2001)

    Article  CAS  Google Scholar 

  86. Falter, R., Wilken, R.D.: Determination of carboplatinum and cisplatinum by interfacing HPLC with ICP MS using ultrasonic nebulisation. Sci. Total Environ. 225, 167–176 (1999)

    Article  CAS  Google Scholar 

  87. Hill, D.M., Barnes, R.K., Wong, H.K., Zawadzki, A.W.: The quantification of technetium in generator-derived pertechnetate using ICP-MS. Appl. Radiat. Isot. 53, 415–419 (2000)

    Article  CAS  Google Scholar 

  88. Edler, M., Jakubowski, N., Linscheid, M.: Styrene oxide DNA adducts: quantitative determination using 31P monitoring. Anal. Bioanal. Chem. 381, 205–211 (2005)

    Article  CAS  Google Scholar 

  89. Beauchemin, D., Kisilevsky, R.: Ionization within a cylindrical capacitor: electrospray without an externally applied high voltage. Anal. Chem. 70, 201–212 (1998)

    Article  Google Scholar 

  90. Abernethy, D.R., DeStefano, A.J., Cecil, T.L., Zaidi, K., Williams, R.L.: Metal impurities in food and drugs. Pharm. Res. 27, 750–755 (2010)

    Article  CAS  Google Scholar 

  91. Murty, A.S.R.K., Kulshresta, U.C., Rao, T.N., Talluri, M.V.: Determination of heavy metals in selected drug substances by inductively coupled plasma – mass spectrometry. Indian J. Chem. Technol. 12, 229–231 (2005)

    CAS  Google Scholar 

  92. Lam, R., Salin, E.D.: Analysis of pharmaceutical tablets by laser ablation inductively coupled plasma atomic emission spectrometry and mass spectrometry (LA ICP AES and LA ICP MS). J. Anal. Atom. Spectrom. 19, 938–940 (2004)

    Article  CAS  Google Scholar 

  93. Ponce de Leon, C.A., Montes-Bayan, M., Caruso, J.A.: Trace element determination in vitamin E using ICP MS. Anal. Bioanal. Chem. 374, 230–234 (2002)

    Article  CAS  Google Scholar 

  94. Kishi, T., Res, J.: Analysis of trace elements in methamphetamine hydrochloride by inductively coupled plasma-mass spectrometry. J. Res. Nat. Bur. Stand. 93, 469–471 (1988)

    Article  CAS  Google Scholar 

  95. Lewen, N., Schenkenberger, M., Larkin, T., Conder, S., Brittain, H.: The determination of palladium in fosinopril sodium (monopril) by ICP MS. J. Pharm. Biomed. Anal. 13, 879–883 (1995)

    Article  CAS  Google Scholar 

  96. Camarasu, C., Madichie, C., Williams, R.: Recent progress in the determination of volatile impurities in pharmaceuticals. Trends Anal. Chem. 25, 768–777 (2006)

    Article  CAS  Google Scholar 

  97. B’Hymer, C.: Residual solvent testing: a review of gas-chromatographic and alternative techniques. Pharm. Res. 20, 337–344 (2003)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, Karol Marcinkowski University of Medical Sciences, Poznan, Poland

    Maciej Stawny & Mikołaj Piekarski

  2. BC Cancer Agency, Center for the North, Pharmacy, Prince George, BC, Canada

    Mikołaj Piekarski

Authors
  1. Maciej Stawny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikołaj Piekarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara Marciniec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maciej Stawny .

Editor information

Editors and Affiliations

  1. Department of Inorganic, Analytical Chemistry & Electrochemistry, Silesian University of Technology, Gliwice, Poland

    Irena Baranowska

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Stawny, M., Piekarski, M., Marciniec, B. (2016). Analysis of Drug Impurities. In: Baranowska, I. (eds) Handbook of Trace Analysis. Springer, Cham. https://doi.org/10.1007/978-3-319-19614-5_8

Download citation

Publish with us

Policies and ethics

Search

Navigation